Publications by authors named "Joseph Gao"

Claim this Profile
D
Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Michael Huss, Keith McBurnett, Andrew J Cutler, Amaia Hervás, Caleb Bliss, Joseph Gao

Eur Neuropsychopharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Cynthia Richards, Roger S McIntyre, Richard Weisler, Angelo Sambunaris, Olga Brawman-Mintzer, Joseph Gao

J Affect Disord· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
Susan L McElroy, James I Hudson, James E Mitchell, Denise Wilfley, M Celeste Ferreira-Cornwell, Joseph Gao

JAMA Psychiatry· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
Maria Gasior, Jon Freeman, Gary Zammit, Patricia Donnelly, Joseph Gao

J Clin Psychopharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A generalized estimating equation approach to analysis of maintenance of wakefulness testing in a study of lisdexamfetamine dimesylate, armodafinil, and placebo in sleep-deprived adults.
Thomas Roth, Jon Freeman, Gary Zammit, Patricia Donnelly, Joseph Gao

J Clin Psychopharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.
Robert A Lasser, Bryan Dirks, Henry Nasrallah, Courtney Kirsch, Joseph Gao

Neuropsychopharmacology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
Madhukar H Trivedi, Andrew J Cutler, Cynthia Richards, Robert Lasser, Brooke B Geibel, Joseph Gao

J Clin Psychiatry· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.
Matthew Brams, John Giblin, Maria Gasior, Joseph Gao, Timothy Wigal

Postgrad Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Timothy Wigal, Matthew Brams, Maria Gasior, Joseph Gao, John Giblin

Postgrad Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
Atilla Turgay, Lawrence Ginsberg, Elias Sarkis, Rakesh Jain, Ben Adeyi, Joseph Gao

J Child Adolesc Psychopharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
Thomas E Brown, Matthew Brams, Joseph Gao, Maria Gasior, Ann Childress

Postgrad Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.
Timothy Wigal, Matthew Brams, Maria Gasior, Joseph Gao, Liza Squires

Behav Brain Funct· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization study.
Robert L Findling, Lawrence D Ginsberg, Rakesh Jain, Joseph Gao

J Child Adolesc Psychopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.
Richard Weisler, Joel Young, Greg Mattingly, Joseph Gao, Liza Squires

CNS Spectr· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
Spotswood L Spruance, Neil Bodsworth, Harvey Resnick, Marcus Conant, Claude Oeuvray, Joseph Gao

J Am Acad Dermatol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
Fred Y Aoki, Stephen Tyring, Francisco Diaz-Mitoma, Gerd Gross, Joseph Gao

Clin Infect Dis· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis